CEACAM1 Expression in Obese Patients' Livers
Author Information
Author(s): Lee Wonae
Primary Institution: Dankook University College of Medicine
Hypothesis
Is decreased CEACAM1 expression in the liver related to obesity and diabetes?
Conclusion
A decreased CEACAM1 expression is associated with obesity and fatty liver, but not specifically with diabetes.
Supporting Evidence
- CEACAM1 expression was decreased in 29% of cases.
- High grade fatty liver was significantly more common in severely obese patients.
- The incidence of decreased CEACAM1 expression was higher in severely obese patients with NASH.
Takeaway
This study found that people who are very obese have less of a certain protein in their liver, which is linked to fat in the liver, but it doesn't seem to be directly related to diabetes.
Methodology
Immunohistochemical evaluation of CEACAM1 expression in liver tissues from 99 subjects.
Potential Biases
Potential bias in selection of subjects from specific hospitals.
Limitations
The study's findings may not apply to all populations due to the specific sample of severely obese patients.
Participant Demographics
Subjects aged 32 to 81, including severely obese patients and non-obese patients with diabetes.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website